Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma, Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06529081
What this trial is testing

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Copernicus Memorial Hospital 165
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Testing effectiveness (Phase 2)Looking for participantsNCT04919382
What this trial is testing

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma+3 more
Dwight Owen 56
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00049218
What this trial is testing

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 56
Testing effectiveness (Phase 2)UnknownNCT00546130
What this trial is testing

Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
University of Toyama 45
Not applicableLooking for participantsNCT04790253
What this trial is testing

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Who this might be right for
Limited Stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 600
Testing effectiveness (Phase 2)Looking for participantsNCT06223711
What this trial is testing

Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Universität des Saarlandes 43
Testing effectiveness (Phase 2)Looking for participantsNCT05903092
What this trial is testing

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerSCLCExtensive Stage Small Cell Lung Cancer+1 more
Hirva Mamdani 84
Large-scale testing (Phase 3)Active Not RecruitingNCT03043872
What this trial is testing

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 987
Large-scale testing (Phase 3)Study completedNCT04005716
What this trial is testing

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
BeiGene 457
Early research (Phase 1)Study completedNCT03085849
What this trial is testing

SGI-110 Plus Durvalumab/Tremelimumab in SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Catherine Shu 2
Testing effectiveness (Phase 2)Ended earlyNCT04101357
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Who this might be right for
Solid TumorExtensive-stage Small Cell Lung Cancer
BioNTech SE 54
Early research (Phase 1)Active Not RecruitingNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT06726148
What this trial is testing

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsExtensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals 280
Not applicableUnknownNCT06530797
What this trial is testing

Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 2,000
Early research (Phase 1)Looking for participantsNCT07113691
What this trial is testing

Iadademstat + SBRT With Atezo in ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Yale University 15
Large-scale testing (Phase 3)Study completedNCT00363415
What this trial is testing

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 908
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)UnknownNCT03804580
What this trial is testing

First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vestre Viken Hospital Trust 100
Next Page